Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. (Q51376929)
Jump to navigation
Jump to search
scientific article published on 15 March 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. |
scientific article published on 15 March 2011 |
Statements
1 reference
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. (English)
1 reference
Mona Boaz
1 reference
Elena Sofer
1 reference
Zipora Matas
1 reference
Margarita Mashavi
1 reference
Marina Shargorodsky
1 reference
15 March 2011
1 reference
1 reference
60
1 reference
9
1 reference
1278-1284
1 reference
Identifiers
1 reference